Shareholders' Equity (Details) $ / shares in Units, $ in Thousands										1 Months Ended					2 Months Ended		7 Months Ended	12 Months Ended
	Dec. 14, 2021 USD ($) $ / shares shares	Oct. 05, 2021 USD ($) shares	Apr. 01, 2021 USD ($) shares	Mar. 10, 2021 USD ($) shares	Mar. 09, 2021 shares	Nov. 03, 2020 USD ($) $ / shares shares	Oct. 11, 2020 USD ($) $ / shares shares	Sep. 01, 2020 USD ($) $ / shares shares	Apr. 01, 2019	Oct. 25, 2021 shares	Nov. 24, 2020 USD ($) shares	Oct. 27, 2020 $ / shares shares	Oct. 27, 2020 USD ($) $ / shares shares	Oct. 13, 2020 USD ($) $ / shares shares	Aug. 31, 2021 USD ($) shares	Mar. 31, 2021 USD ($) shares	Dec. 31, 2021 USD ($) $ / shares shares	Dec. 31, 2021 USD ($) $ / shares shares		Dec. 31, 2020 USD ($) shares		Dec. 23, 2020 shares	Oct. 05, 2020 USD ($) shares
Shareholders' Equity (Details) [Line Items]
Loan amount (in Dollars) | $																				$ 190
Accrued interest (in Dollars) | $																				$ 87
Converted shares | shares																				1,045,521
Restricted stock unit shares issued | shares	144,000										7,500					30,000							7,500
Issuance of shares | shares															47,134
Number of directors	5										1				3	2
Fair value of RSU's (in Dollars) | $	$ 111							$ 30			$ 128					$ 334							$ 18
Issuance of shares | shares																	830,000
Promissory Notes (in Dollars) | $																	$ 830	$ 830
Fair value (in Dollars) | $															$ 106
Number of options granted | shares																		227,500	[1],[2],[3]	103,500	[4],[5]
Options expire date																		Sep. 11, 2024
Share-based expenses (in Dollars) | $																		$ 1,318		$ 171
Exercisable per share (in Dollars per share) | $ / shares																	$ 0.7	$ 0.7
RSU’s vest quarterly years	1 year
Consultant [Member]
Shareholders' Equity (Details) [Line Items]
Issuance of shares | shares		29,167								40,000
Exercised options | shares		50,000								40,000
RSU [Member]
Shareholders' Equity (Details) [Line Items]
Share issued | shares																						60,000
Restricted stock unit shares issued | shares			10,000	50,000							30,000											60,000
Issuance of shares | shares			10,000	50,000	13,025
Number of directors			2	2							2
Fair value of RSU's (in Dollars) | $			$ 59	$ 275
Share-based expenses (in Dollars) | $																		$ 10		3
Granted share | shares								36,000
RSU’s vest quarterly years								3 years
RSU [Member] | Director [Member]
Shareholders' Equity (Details) [Line Items]
Restricted stock unit shares issued | shares		7,500
Issuance of shares | shares		7,500
Fair value of RSU's (in Dollars) | $		$ 18
Ordinary share [Member]
Shareholders' Equity (Details) [Line Items]
Common stock voting rights																		Each Ordinary share is entitled to receive dividend, participate in the distribution of the Company’s net assets upon liquidation and to receive notices of participate and vote (at one vote per share) at the general meetings of the Company on any matter upon which the general meeting is authorized.
Option [Member]
Shareholders' Equity (Details) [Line Items]
Number of options granted | shares						50,000	1,000	15,000				40,000		100,000
Purchase of shares | shares						50,000	1,000	15,000				40,000	40,000	100,000
Price per share (in Dollars per share) | $ / shares							$ 3	$ 0.7						$ 1
Options expire date							Mar. 11, 2021	Sep. 01, 2025						Oct. 13, 2023
Fair value of stock options (in Dollars) | $						$ 25	$ 1	$ 13					$ 23	$ 60
Share price (in Dollars per share) | $ / shares						$ 0.51	$ 0.6475	$ 0.835				$ 0.5	$ 0.5	$ 0.61
Exercise price (in Dollars per share) | $ / shares							$ 3	$ 0.7				0.001	$ 0.001	$ 1
Maturity term						4 years 11 months 4 days	1 year 25 days	5 years					1 year	3 years
Volatility						278.00%	285.00%	296.00%					237.00%	286.00%
Dividend yield						0.00%	0.00%	0.00%					0.00%	0.00%
Risk free rate						0.39%	0.27%	0.26%					0.12%	0.31%
Description of stock option						25,000 options are exercisable at $1.00 per Share and 25,000 options are exercisable at $1.50 per share. The options vest quarterly over one year.								the Company, through Saffron, signed a contract with a consultant pursuant to which they were granted 100,000 options to purchase 100,000 shares at $1.00 per share. 25,000 options vest immediately, and the remaining 75,000 vest in three equal amounts every six months thereafter. The options expire on October 13, 2023.
Exercisable per share (in Dollars per share) | $ / shares												$ 0.001	$ 0.001
Option One [Member]
Shareholders' Equity (Details) [Line Items]
Share-based expenses (in Dollars) | $																		$ 6		4
Option Two [Member]
Shareholders' Equity (Details) [Line Items]
Share-based expenses (in Dollars) | $																				1
Option Three [Member]
Shareholders' Equity (Details) [Line Items]
Share-based expenses (in Dollars) | $																		30		27
Option Four [Member]
Shareholders' Equity (Details) [Line Items]
Share-based expenses (in Dollars) | $																		17		$ 9
Option Five [Member]
Shareholders' Equity (Details) [Line Items]
Share-based expenses (in Dollars) | $																		23
Option Six [Member]
Shareholders' Equity (Details) [Line Items]
Number of options granted | shares	80,000
Purchase of shares | shares	80,000
Fair value of stock options (in Dollars) | $	$ 56
Share price (in Dollars per share) | $ / shares	$ 0.7
Exercise price (in Dollars per share) | $ / shares	$ 0.01
Maturity term	5 years
Volatility	221.00%
Dividend yield	0.00%
Risk free rate	1.23%
Share-based expenses (in Dollars) | $																		$ 36
Description of stock option	the Company, through Saffron, signed a contract with an employee pursuant to which they were granted 80,000 options to purchase 80,000 shares. All options are exercisable at $0.01 per Share. 50,000 options vest immediately, and 30,000 options vest quarterly over two years.
Exercisable per share (in Dollars per share) | $ / shares	$ 0.01
Minimum [Member] | Option [Member]
Shareholders' Equity (Details) [Line Items]
Exercise price (in Dollars per share) | $ / shares						$ 1
Maximum [Member] | Option [Member]
Shareholders' Equity (Details) [Line Items]
Exercise price (in Dollars per share) | $ / shares						$ 1.5
2018 Plan [Member]
Shareholders' Equity (Details) [Line Items]
Awards granted, descriptions									Awards granted under the 2018 Plan are subject to vesting schedules and unless determined otherwise by the administrator of the 2018 Plan, generally vest following a period of four years from the applicable vesting commencement date, such that the awards vest in four annual equal instalments and/or generally vest following a period of one year from the applicable vesting commencement date, such that the awards vest in four quarterly equal instalments.

[1] On December 14, 2021, the Company granted five directors 144,000 RSU’s. The fair value of the shares at the date of the grant was $111. The RSU’s vest quarterly in advance over one year.

[2] On October 27, 2020, the Company, through Saffron, signed a contract with a consultant pursuant to which they were granted 40,000 options to purchase 40,000 shares. All options are exercisable at $0.001 per Share. The options vest immediately. The fair value of the stock options issued is $23 and was determined using the Black-Scholes option pricing model and the following assumptions: share price - $0.50; exercise price - $0.001; expected life – 1 year; annualized volatility – 237%; dividend yield – 0%; risk free rate – 0.12%. During the years ended December 31, 2021 and 2020, the Company recorded share-based expenses related to the options in the amount of $23 and $nil, respectively.

[3] On October 5, 2021, the Company granted a director 7,500 RSU’s. The fair value of the shares at the date of the grant was $18.

[4] On November 24, 2020, The Company granted two directors 30,000 RSU’s each, and one director 7,500 RSU’s. All these RSU’s vest immediately and have an exercise price of nil. The fair value of the RSU’s at the date of the grant was $128.

[5] On September 1, 2020, the Company, the Company granted the CFO 36,000 RSU’s with an exercise price of nil. The RSU’s vest quarterly over three years. The fair value of the RSU’s at the date of the grant was $30. During the years ended December 31, 2021 and 2020, the Company recorded share-based expenses related to the RSU’s in the amount of $10 and $3, respectively